Search Results 781-790 of 11043 for SC
... SC, Lerman LO. Elevated urinary podocyte-derived extracellular microvesicles in renovascular hypertensive patients. Nephrol Dial Transplant. 2017 May 1; 32 ...
In Part B (dose expansion), potential therapeutic doses may be studied with SC-004 as monotherapy and SC-004 in combination with ABBV-181 in disease-specific ...
Johnston SC. S C; Gress DR. D R; Browner WS. W S; Sidney S. S. JAMA. 2000. Dec; 284(22):2901-6. Management of patients with acute transient ischemic attack ...
The purpose of this study is to evaluate the effectiveness, safety, and pharmacokinetics of mosunetuzumab subcutaneous (SC) formulation in participants with ...
It is acceptable to have patients temporarily switched to Octreotide s.c. (up to six weeks) in order to obtain an OctreoScan®, provided they return to the same ...
History of intolerance to SC injection(s) or significant abdominal scarring that could potentially hinder study drug administration or evaluation of local ...
This is a multicenter, open-label, Phase 1 study in participants with colorectal cancer (CRC) or gastric cancer to study the safety and tolerability of SC ...
Find additional videos from the Mayo Clinic Spontaneous Coronary Artery Dissection (SCAD) Research Program.
Sponsor Protocol Number: SC-VLU-001. About this study. To assess the safety and tolerability of multiple ascending doses of Aurase Wound Gel when administered ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your gift today can have 5X the impact on AI research and technology. But hurry — the match challenge ends 9/19.